Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL4887236

CS(=O)(=O)Nc1ccc(CN)cc1.O=C(O)C(F)(F)F

nearest known ligand 0.53

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.53
SMN1; SMN2 Q16637 2/20 0.53
HPGD P15428 2/20 0.53
ALDH1A1 P00352 1/20 0.53
LMNA P02545 1/20 0.53
HTT P42858 1/20 0.53
KIF11 P52732 3/20 0.46
ITGB3 P05106 2/20 0.46
ITGB1 P05556 2/20 0.46
ITGAV P06756 2/20 0.46
ITGA5 P08648 2/20 0.46
EPHX2 P34913 1/20 0.46
NR1H4 Q96RI1 1/20 0.46
ITGB2 P05107 1/20 0.44
ITGB5 P18084 1/20 0.44
ITGB6 P18564 1/20 0.44
ITGAL P20701 1/20 0.44
KEAP1 Q14145 1/20 0.44
TRPV1 Q8NER1 1/20 0.44
CA12 O43570 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL5309778 0.87 HPGD (0.54) KDM4ESMN1; SMN2HPGDLMNAHTT
Trifluoroacetic Acid SCHEMBL5315182 0.86 SMN1; SMN2 (0.54) KDM4ESMN1; SMN2ITGB3ITGB1ITGAV
Trifluoroacetic Acid SCHEMBL2480625 0.86 HTR6 (0.55) SMN1; SMN2ALDH1A1KIF11KEAP1
SCHEMBL1752626 0.85 HPGD (0.70) KDM4ESMN1; SMN2HPGDALDH1A1LMNA
Hydrochloric Acid SCHEMBL1998551 0.84 HPGD (0.68) KDM4ESMN1; SMN2HPGDALDH1A1LMNA
Trifluoroacetic Acid SCHEMBL5307840 0.81 HTR6 (0.61) ALDH1A1KEAP1CA12CA1CA2
Trifluoroacetic Acid SCHEMBL5311009 0.78 ITGB3 (0.54) SMN1; SMN2ALDH1A1HTTITGB3ITGB1
Trifluoroacetic Acid SCHEMBL5315234 0.76 ALDH1A1 (0.45) SMN1; SMN2ALDH1A1KIF11
Trifluoroacetic Acid SCHEMBL4640607 0.76 KDM4E (0.49) KDM4ESMN1; SMN2HPGDALDH1A1LMNA
Trifluoroacetic Acid SCHEMBL7850280 0.75 ALDH1A1 (0.48) KDM4ESMN1; SMN2ALDH1A1ITGB3ITGB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8071650-B2 Vanilloid receptor modulators; analgesic, antiinflammatory and antiulcer effects; such as 1-(1H-indol-5-ylmethyl)-3-phenethylthiourea PACIFIC CORPORATION (KR) 2011-12-06 US disclosed
US-20080064687-A1 Novel thiourea derivatives and the pharmaceutical compositions containing the same SUH YOUNG G 2008-03-13 US disclosed
WO-2007047575-A2 PHARMACOLOGICAL TREATMENTS FOR SLEEP-RELATED BREATHING DISORDERS THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) 2007-04-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080064687-A1 Novel thiourea derivatives and the pharmaceutical compositions containing the same TRPV1, TRPA1, TAS2R5 KDM4E 4511/4885SMN1; SMN2 1383/4885HPGD 1443/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.